Ikarian Capital, LLC Applied Genetic Technologies Corp Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.62 - $1.1 $255,621 - $453,522	-412,293 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.07 - $2.71 $23,431 - $59,346	21,899 Added 5.61%	412,293 $440,000
Q3 2021 Nov 15, 2021	SELL	$3.01 - $4.12 $76,724 - $105,018	-25,490 Reduced 6.13%	390,394 $1.18 Million
Q1 2021 May 17, 2021	SELL	$3.94 - $8.19 $512,200 - $1.06 Million	-130,000 Reduced 23.81%	415,884 $2.11 Million
Q1 2020 May 15, 2020	BUY	$2.36 - $9.86 $814,200 - $3.4 Million	345,000 Added 171.74%	545,884 $1.79 Million
Q4 2019 Jan 31, 2020	BUY	$2.69 - $4.92 $540,377 - $988,349	200,884 New	200,884 $908,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.